The introduction of a 750mcg parathyroid hormone injection in Australia has been cautiously managed, with access primarily via specialist clinicians and designated clinics . Preliminary sales figures for this higher dosage remain unavailable from the manufacturer , although experts suggest moderate adoption rates . Availability to patients is gover